 |
|
| GLAUCOMA: AN OPEN-WINDOW TO NEURODEGENERATION AND NEUROPROTECTION, 173
| |
| | |
|
|
To order this title, and for more information, click here
Edited By
Carlo Nucci, University of Rome Tor Vergata, Italy
Luciano Cerulli
Neville Osborne, Oxford University, UK
Giacinto Bagetta, University of Calabria, Arcavata di Rende, Italy
Included in series
Progress in Brain Research, 173
Audience
Neuroscientists, neurologists, opthalmologists, neuropharmacologists
Contents
EPIDEMIOLOGY AND CLINICAL ASSESSMENT OF THE DISEASE
1. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects
C. Cedrone, R. Mancino, A. Cerulli, M. Cesareo and C. Nucci (Italy)
2. Predictive models to estimate the risk of glaucoma development
and progression
F.A. Medeiros and R.N. Weinreb (USA)
3. Intraocular pressure and central corneal thickness
G. Manni, F. Oddone,
V. Parisi, A. Tosto and M. Centofanti (Italy)
4. Angle-closure: risk factors, diagnosis and treatment
N. Amerasinghe and T. Aung
(Singapore)
5. Early diagnosis in glaucoma
D.F. Garway-Heath (UK, Italy)
6. Monitoring glaucoma progression
P. Brusini (Italy)
ANATOMICAL AND FUNCTIONAL MONITORING
7. Standard automated perimetry and algorithms for monitoring glaucoma progressions
G.L. Scuderi,
M. Cesareo, A. Perdicchi and S.M. Recupero (Italy)
8. Short-wavelength automated perimetry and frequency-doubling technology perimetry
in glaucoma
P. Fogagnolo, L. Rossetti, S. Ranno, A. Ferreras and N. Orzalesi (Italy, Spain)
9. Scanning laser polarimetry and
confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma
F. Ferreri, P. Aragona and G. Ferreri (Italy)
10. The role of OCT in glaucoma management (Italy)
11. Functional laser Doppler flowmetry of the optic nerve: physiological aspects
and clinical applications
C.E. Riva and B. Falsini (Italy)
12. Advances in neuroimaging of the visual pathways and their use in
glaucoma
F.G. Garaci, V. Cozzolino, C. Nucci, F. Gaudiello, A. Ludovici, T. Lupattelli, R. Floris and G. Simonetti (Italy)
CURRENT
THERAPY
13. Primary open angle glaucoma: an overview on medical therapy
M. Vetrugno, F. Cantatore, G. Ruggeri, P. Ferreri, A. Montepara,
A. Quinto and C. Sborgia (Italy)
14. The treatment of normal tension glaucoma
P.V. Desai and J. Caprioli (USA)
15. The management
of exfoliative glaucoma
R. Rich (USA)
16. Laser therapies for glaucoma: new frontiers
G.L. Scuderi and N. Pasquale (Italy)
17. Modulation of wound healing during and after glaucoma surgery
S. Georgoulas, A. Dahlmann-Noor, S. Brocchini and P.-T. Khaw
(UK)
18. Surgical alternative to trabeculectomy
R.G. Carassa (Italy)
19. Modern aqueous shunt implantation C future challenges
K. Barton and D.K. Heuer (London, UK and Milwaukee, USA)
EXPERIMENTAL APPROACHES TO MODEL DISEASE
20. Model systems for experimental
studies: retinal ganglion cells in culture
E. Goodyear, and L.A. Levin (Canada)
21. Rat models for glaucoma research
J.C.
Morrison, E. Johnson and W.O. Cepurna (USA)
22. Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration
and neuroprotection
R. Howell, R.T. Libby and S.W.M. John (USA)
23. Clinical trials in neuroprotection
S.M. Whitcup (USA)
NEUROPROTECTION: NEW VISTAS IN PATHOPHYSIOLOGY
24. Pathogenesis of ganglion cells in glaucoma and neuroprotection: Focus on ganglion
cell axonal mitochondria
N.N. Osborne (UK)
25. Astrocytes in glaucomatous optic neuropathy
M.R. Hernandez, H. Miao and
T. Lukas (USA)
26. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation
M. Schwartz and A. London (Israel)
27. Oxidative stress and glaucoma. Injury in the anterior segment of the eye
S.C. Sacca and A. Izzotti (Italy)
28. TNF-alpha
signalling in glaucomatous neurodegeneration
G. Tezel (USA)
29. Involvement of the Bcl2 gene family in the signalling and control
of retinal ganglion cell death
R.W. Nickells, S.J. Semaan and C.L. Schlamp (USA)
30. Assessment of neuroprotection in the retina
with DARC
L.Guo and M.F. Cordeiro (UK)
31. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular
pressure control to neuroprotection
C. Nucci, M. Bari, A. Spano, M.T. Corasaniti,, G. Bagetta, M. Maccarrone and L.A. Morrone
(Italy)
32. Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration
Y. Y cel and N. Gupta
(USA)
33. Changes of central visual receptive fields in experimental glaucoma
S.C. Sharma (USA)
NEUROPROTECTION: EVIDENCE FOR
FUTURE STRATEGIES
34. Targeting excitotoxic/free radical signalling pathways for therapeutic intervention in glaucoma
M. Seki and
S.A. Lipton (USA)
35. Stem cells for neuroprotection in glaucoma
N.D. Bull, T.V. Johnson and K.R. Martin (UK)
36. The relationship
between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells
N.G.F. Cooper, A. Laabich, W. Fan and
X. Wang (USA)
37. Evidence of the neuroprotective role of Citicoline in glaucoma patients
V. Parisi, G. Coppola, M. Centofanti,
F. Oddone, A.-M. Angrisani, L. Ziccardi, B. Ricci, L. Quaranta and G. Manni (Italy)
38. Neuroprotection: VEGF, IL-6 and cluster in
the dark side of the moon
S. Pucci, P. Mazzarelli, F. Missiroli, F. Regine and F. Ricci (Italy)
39. Rational basis for the development
of coenzyme Q10 as a neurotherapeutic agent for retinal protection
R. Russo, F. Cavaliere, L. Rombol , M. Gliozzi, A. Cerulli,
C. Nucci, E. Fazzi, G. Bagetta, M.T. Corasaniti and L.A. Morrone (Italy)
40. 17 beta-estradiol prevents retinal ganglion cell loss
induced by acute rise of intraocular pressure in rat
R. Russo, F. Cavaliere F., C. Watanabe, C. Nucci, G. Bagetta, M. T. Corasaniti,
S. Sakurada and L. A. Morrone (Italy, Japan)
| Bibliographic details |
Hardbound, 616 pages, publication date: NOV-2008
ISBN-13: 978-0-444-53256-5
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
GBP 151.99
USD 250
EUR 178.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
095/945
Last update: 25 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company